Prof Sir Rory Collins, UK Biobank Principal Investigator and Chief Executive Officer, Oxford University
Sir Mike Rawlins, Chair, UK Biobank Board
Dr Wendy Ewart, Deputy Chief Executive and Director of Strategy, Medical Research Council
Prof Danny Altmann, Head of Pathogens, Immunology and Population Health at Wellcome
Ten years and almost £100m in the planning and development, UK Biobank is one of the most detailed large-scale health projects ever developed. Speakers from the UK Biobank and funders came to announce the opening of the data for use by scientists.